Bringing science and development together through original news and analysis

  • WHO plans to 'strangle' drug-resistant TB

The World Health Organization (WHO) has announced a new two-year, US$2.15 billion plan to prevent, treat and control drug-resistant tuberculosis.

If fully implemented, hundreds of thousands of drug-resistant tuberculosis (TB) cases could be prevented and the lives of 1.2 million patients saved.

The 'Global MDR-TB and XDR-TB Response Plan 2007-2008', launched 22 June, details the steps required to provide access to drugs and diagnostic tests for all drug-resistant TB patients by 2015, and identifies costs, milestones and priorities for health services.

The WHO has expressed concern over the rising incidence of drug resistance in TB patients, which can emerge when patients do not take medication at the prescribed dose and intervals.

The new WHO plan outlines steps to increase the number of TB laboratories in countries with high levels of TB so that detection and treatment of resistant cases can be increased ten-fold.

Eighty per cent of the budget will be designated for country needs, with the remaining sum to support global, regional and national activities by international partners.

The WHO estimates there are 424,000 new cases of multidrug-resistant TB (MDR-TB) each year, where patients do not respond to the two main first-line anti-TB drugs, rifampicin and isoniazid. It says the cost of treating MDR-TB is 1,000 times higher than treating ordinary TB patients.

Extensively drug-resistant (XDR-TB) is a virtually untreatable form of MDR-TB, where patients do not respond to at least four anti-TB drugs. The WHO estimates 25,00030,000 new cases of XDR-TB every year.

Thirty-seven countries have reported cases of XDR-TB since it was first highlighted in 2006, when South Africa reported a cluster of "virtually untreatable" XDR-TB cases in an area with high HIV prevalence. 52 of the 53 patients died within 25 days of diagnosis.

"It is an ambitious plan that must be fully supported if we are to keep a stranglehold on drug-resistant TB," says Mario Raviglione, director of the WHO's Stop TB Department, in a press release.

The India office of the international organisation Mdecins Sans Frontires (MSF) said in a report released on World TB Day (24 March) that resistant strains of tuberculosis are spreading at alarming rates due to lack of adequate tools to diagnose, treat or prevent them.

Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.